(Q44070833)

English

In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

Takeo Funakoshi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shigeyuki Chaki

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Naoya Kawashima

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yoshiko Suzuki

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ryoko Yoshikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Toshihito Kumagai

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Atsuro Nakazato

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kazuya Kameo

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Makoto Goto

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shigeru Okuyama

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1371-1384

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Positive and negative symptoms in schizophrenia. A critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Clozapine. A novel antipsychotic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Pilot Clinical Investigation of Risperidone in the Treatment of Psychotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

The role of 5-HT2A receptors in antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

NE-100, a novel sigma receptor ligand: in vivo tests

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Adverse effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Seizure associated with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Effect of desipramine on dopamine receptor binding in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901863-5

7 January 2021

Identifiers

10.1016/S0024-3205(02)01863-5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44070833&oldid=2106254378"